Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125316031 | 12531603 | 1 | I | 20160628 | 20160706 | 20160706 | EXP | JP-MYLANLABS-2016M1027827 | MYLAN | MITO A, YAMASAKI M, MATSUURA K, KAJIHARA T, NITTA T, AWAYA H, ET AL. CLINICAL INVESTIGATION OF WEEKLY CARBOPLATIN AND PACLITAXEL WITH CONCURRENT RADIATION THERAPY FOR LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER. GAN-TO-KAGAKU-RYOHO 2009;36(10):1653-1656. | 0.00 | Y | 0.00000 | 20160706 | OT | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125316031 | 12531603 | 1 | PS | CARBOPLATIN. | CARBOPLATIN | 1 | Unknown | ON DAYS 1, 8, 15, 22, 29, AND 36 | 91063 | ||||||||||
125316031 | 12531603 | 2 | SS | PACLITAXEL. | PACLITAXEL | 1 | Unknown | ON DAYS 1, 8, 15, 22, 29, AND 36 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125316031 | 12531603 | 1 | Non-small cell lung cancer stage III |
125316031 | 12531603 | 2 | Non-small cell lung cancer stage III |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125316031 | 12531603 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125316031 | 12531603 | Pneumonitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |